Back
Akebia Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Buy
66
AKBA
Akebia Therapeutics
Last Price:
1.86
Seasonality Move:
32.87%
Sell
37
LLY
Eli Lilly and
Last Price:
806.37
Seasonality Move:
3.94%
Buy
66
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $1.86. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $806.06. The Score for LLY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKBA is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $806.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing slight buying pressure.
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 78.3 | Buy |
Chaikin Money Flow: | 2495662 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 1.67) | Buy |
Bollinger Bands (100): | (1.12 - 1.54) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -23.59 | Sell |
Relative Strength Index (14 RSI): | 23.64 | Sell |
Chaikin Money Flow: | 1666322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (852.08 - 924.68) | Sell |
Bollinger Bands (100): | (851.07 - 940.27) | Sell |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.71 | Buy |
20-day SMA: | 1.52 | Buy |
50-day SMA: | 1.44 | Buy |
200-day SMA: | 1.39 | Buy |
8-day EMA: | 1.72 | Buy |
20-day EMA: | 1.58 | Buy |
50-day EMA: | 1.47 | Buy |
200-day EMA: | 1.34 | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 849.95 | Sell |
20-day SMA: | 888.14 | Sell |
50-day SMA: | 905.66 | Sell |
200-day SMA: | 827.18 | Sell |
8-day EMA: | 840.9 | Sell |
20-day EMA: | 871.82 | Sell |
50-day EMA: | 888.86 | Sell |
200-day EMA: | 815.89 | Sell |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.91 per share, and an increase next year of $9.61 per share.
Akebia Therapeutics Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |